CSIMarket Company Name, Ticker, Customers, else..
 
Kiromic Biopharma Inc   (KRBP)
 

Kiromic Biopharma Inc's Suppliers Performance

KRBP's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
KRBP Costs vs Sales of Suppliers Growth

• More on KRBP Suppliers






Kiromic Biopharma Inc's Comment on Supply Chain


The company manages raw materials and final products for manufacturing within a facility that includes backup pods for product development and a dedicated waste storage area. It operates a Quality Control Laboratory with analytical testing, as well as Microbiology and Environmental Monitoring Laboratories, all equipped with HEPA-filtered air to ensure cleanliness and process isolation. The company anticipates requiring additional manufacturing capacity if product candidates receive approval for commercial distribution. Manufacturing operations benefit from in-house cGMP production, providing full control and vertical integration of vector and cell therapy production, which reduces lead times and production costs. The facility supports outpatient treatment, potentially lowering hospitalization costs.

Kiromic Biopharma Inc's Comment on Supply Chain


The company manages raw materials and final products for manufacturing within a facility that includes backup pods for product development and a dedicated waste storage area. It operates a Quality Control Laboratory with analytical testing, as well as Microbiology and Environmental Monitoring Laboratories, all equipped with HEPA-filtered air to ensure cleanliness and process isolation. The company anticipates requiring additional manufacturing capacity if product candidates receive approval for commercial distribution. Manufacturing operations benefit from in-house cGMP production, providing full control and vertical integration of vector and cell therapy production, which reduces lead times and production costs. The facility supports outpatient treatment, potentially lowering hospitalization costs.







KRBP's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Kiromic Biopharma Inc 0.00 0.00 -26.90 16
SUBTOTAL 0.00 0.00 0.00 -


Sources: Kiromic Biopharma Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Kiromic Biopharma Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.